Cracking the Code: Brazil's Complex Import Taxes for Korean MedTech

This episode delves into the single most significant barrier for Korean medical device manufacturers entering the Brazilian market: the intricate and burdensome import taxation system. We break down the multiple federal and state-level taxes—including II, IPI, PIS, COFINS, and ICMS—that can collectively exceed 60% of a product's value, and explain why a nuanced understanding of landed costs and product classification is essential for success. - Why is Brazil's import tax system so challenging for Korean MedTech companies? - What are the five key taxes levied on imported medical devices in Brazil? - How can the total tax burden impact the competitiveness of your product? - Why does the importing state in Brazil change the final cost of your device? - What is a 'landed cost' and why is it critical to calculate it accurately? - How does Brazil's tax structure differ from Korea's import duties? - What strategic adjustments must Korean companies make to their pricing for the Brazilian market? Pure Global provides end-to-end regulatory consulting for MedTech and IVD firms, streamlining global market access with local expertise and advanced AI. We help you develop efficient regulatory strategies, manage technical dossier submissions, and navigate complex markets like Brazil. Our services include acting as your local representative in over 30 countries and ensuring continuous regulatory monitoring. By integrating technology and deep market knowledge, we help you overcome barriers and accelerate your entry into new territories. For a strategic partner in your global expansion, contact us at [e-mail], visit https://pureglobal.com, or explore our free AI tools at https://pureglobal.ai.